Journal article 496 views 29 downloads
Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms
Nature Communications, Volume: 8, Issue: 1
Swansea University Author: Lydia Powell
-
PDF | Version of Record
© The Author(s) 2017. This article is licensed under a Creative Commons Attribution 4.0 International License
Download (2.15MB)
DOI (Published version): 10.1038/s41467-017-02149-0
Abstract
MCR-1 is a lipid A modifying enzyme that confers resistance to the antibiotic colistin. Here, we analyse the impact of MCR-1 expression on E. coli morphology, fitness, competitiveness, immune stimulation and virulence. Increased expression of mcr-1 results in decreased growth rate, cell viability, c...
Published in: | Nature Communications |
---|---|
ISSN: | 2041-1723 |
Published: |
Springer Science and Business Media LLC
2017
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa61622 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract: |
MCR-1 is a lipid A modifying enzyme that confers resistance to the antibiotic colistin. Here, we analyse the impact of MCR-1 expression on E. coli morphology, fitness, competitiveness, immune stimulation and virulence. Increased expression of mcr-1 results in decreased growth rate, cell viability, competitive ability and significant degradation in cell membrane and cytoplasmic structures, compared to expression of catalytically inactive MCR-1 (E246A) or MCR-1 soluble component. Lipopolysaccharide (LPS) extracted from mcr-1 strains induces lower production of IL-6 and TNF, when compared to control LPS. Compared to their parent strains, high-level colistin resistance mutants (HLCRMs) show reduced fitness (relative fitness is 0.41–0.78) and highly attenuated virulence in a Galleria mellonella infection model. Furthermore, HLCRMs are more susceptible to most antibiotics than their respective parent strains. Our results show that the bacterium is challenged to find a delicate equilibrium between expression of MCR-1-mediated colistin resistance and minimalizing toxicity and thus ensuring cell survival. |
---|---|
College: |
Faculty of Medicine, Health and Life Sciences |
Funders: |
e thank Dr Jonathan Tyrell (Division of Infection and Immunity, Cardiff University) for useful suggestions on Galleria infection model, Dr M. Toleman (Division of Infection and Immunity, Cardiff University) for his valuable advice on genome sequencing, and Professor W. Jiang (Cardiff China Medical Research Collaborative, Cardiff University) for access to qPCR machine (Applied BiosystemsTM StepOnePlus®, UK). This work was supported by MRC grant DETER-XDR-CHINA (MR/P007295/1). Q.Y. is funded by a CSC Scholarship. D.O.A. benefits a Geneva University Hospitals (HUG) and Swiss National Science Foundation (P300PB_171601) overseas fellowship. P.N. and U.T. are funded by Royal Golden Jubilee-PhD Program from Thailand Research Fund and Rajamangala University of Technology Lanna (PHD/0054/2555). |
Issue: |
1 |